Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "regulatory-approval"

337 News Found

AstraZeneca's India revenue climbs 33% YoY to Rs. 22.76 billion in FY26
News | June 01, 2026

AstraZeneca's India revenue climbs 33% YoY to Rs. 22.76 billion in FY26

While oncology contributed Rs. 16,100.9 million to remain company's largest therapy area, the key highlight was receipt of 11 new regulatory approvals for medicines and indications


Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm
Opinion | June 01, 2026

Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm

We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms


Pfizer and Innovent Biologics strike $10 billion cancer drug deal
News | June 01, 2026

Pfizer and Innovent Biologics strike $10 billion cancer drug deal

This alliance, covering up to 12 antibody drugs, highlights the growing trend of large-scale collaborations between Chinese biotech firms and global pharmaceutical giants


Abbott secures CE mark for first dual glucose-ketone monitoring systems
Medical Device | May 29, 2026

Abbott secures CE mark for first dual glucose-ketone monitoring systems

Libre Duo devices become the first glucose-ketone monitors approved for diabetes care, offering real-time alerts for diabetic ketoacidosis risk


Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention
News | May 27, 2026

Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention

Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.


Shaily gets regulatory nod for launch of ShailyPen Neo device technology
Medical Device | May 20, 2026

Shaily gets regulatory nod for launch of ShailyPen Neo device technology

The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval


Cipla achieves highest-ever annual revenue of Rs. 28,163 crore in FY26
News | May 15, 2026

Cipla achieves highest-ever annual revenue of Rs. 28,163 crore in FY26

The company witnesses strong growth across its India, Africa, and emerging markets businesses, while securing regulatory approval for the first AB-rated gVentolin in the U.S. market


Indoco Remedies' Baddi plant gets EU GMP approval from Malta Medicines Authority
Drug Approval | May 15, 2026

Indoco Remedies' Baddi plant gets EU GMP approval from Malta Medicines Authority

The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026


From lab bench to market: Strengthening translational research in India’s biotech ecosystem
Opinion | May 11, 2026

From lab bench to market: Strengthening translational research in India’s biotech ecosystem

India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells


Co-Diagnostics JV leases manufacturing facility in Saudi Arabia
Medical Device | May 11, 2026

Co-Diagnostics JV leases manufacturing facility in Saudi Arabia

CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City